Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
PURETECH HEALTH PLC |
Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 157.35 GBX | +0.61% | -4.29% | -40.96% | |
| Nov. 17 | PureTech hails schizophrenia trial results for Karuna drug | AN |
| Nov. 17 | UK retail sales fall; AstraZeneca gets US approval | AN |
Chart calendar PureTech Health plc
a26c9b16fba8c1e6480d0f42486142e.XnSkaV8IpShnsM0lACrVSqnxGO-yW4nmr9btNJY_WK4.KQX9HSZX31gm9YJXTVLsCeTDaKnLNfHWloHYRvkMbu0XTeo8bjnJXCjc9Q~f2605368f36018613cea894f05eecc83
Upcoming events on PureTech Health plc
Past events on PureTech Health plc
| Today | Evercore ISI HealthCONx Conference |
| 2023-11-15 03:00 am | Jefferies London Healthcare Conference |
| 2023-08-29 09:00 am | Q2 2023 Earnings Call |
| 2023-08-29 02:00 am | Q2 2023 Earnings Release |
| 2023-06-13 11:00 am | Annual General Meeting |
| 2023-06-07 01:30 pm | Jefferies Global Healthcare Conference |
| 2023-04-28 09:00 am | Q4 2022 Earnings Call |
| 2023-04-28 02:00 am | Q4 2022 Earnings Release |
| 2023-03-14 04:05 pm | Barclays Global Healthcare Conference |
| 2023-02-15 10:40 am | SVB Securities Global Biopharma Conference |
| 2023-01-10 05:15 pm | JP Morgan Healthcare Conference |
| 2022-12-11 | American Society of Hematology Meeting |
| 2022-11-30 08:50 am | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2022-11-29 01:30 pm | Piper Sandler Healthcare Conference |
| 2022-11-16 10:50 am | Jefferies London Healthcare Conference |
| 2022-11-08 03:50 pm | Credit Suisse Healthcare Conference |
| 2022-09-14 02:05 pm | Morgan Stanley Global Healthcare Conference |
| 2022-08-25 09:00 am | Interim 2022 Earnings Call |
| 2022-08-25 02:01 am | Interim 2022 Earnings Release |
| 2022-08-08 08:00 am | Phase 3 EMERGENT-2 Trial Results Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,7 21,0 -1.2% | 9,81 28,4 -65.47% | 11,8 17,0 -30.82% | 17,4 12,8 35.65% | 15,6 7,40 111.05% | 9,53 |
|
EBITDA Million USD | Released Forecast Spread | -102 -69,1 -47.02% | -129 -113 -13.83% | -113 -104 -8.96% | -143 -120 -18.72% | -189 -166 -13.8% | -171 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -135 -124 -9.37% | -120 -112 -7.09% | -150 -141 -6.24% | -198 -181 -9.29% | -187 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,4 -86,0 20.44% | 478 -91,5 623.05% | 19,0 59,1 -67.88% | -59,0 -145 59.32% | -92,8 -182 48.88% | -149 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 421 17,9 2252.76% | 5,99 94,3 -93.66% | -60,6 -146 58.53% | -50,4 -100 49.67% | -146 |
|
EPS USD | Released Forecast Spread | -0,16 -0,08 -100.5% | 1,44 -0,29 599.77% | 0,02 0,08 -74.91% | -0,21 -0,48 55.96% | -0,18 -0,64 71.65% | -0,57 |
| Announcement Date | 04/24/19 | 04/09/20 | 04/15/21 | 04/26/22 | 04/28/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,39 15,1 -70.95% | 5,42 36,6 -85.19% | 6,84 | 4,92 8,70 -43.4% | 5,84 6,05 -3.54% | 11,6 6,62 74.5% | 7,03 7,52 -6.56% | 8,59 7,80 10.1% | 3,15 102 -96.92% | 11,2 |
|
EBIT Million USD | Released Forecast Spread | -70,3 -45,0 -56.26% | -65,1 -23,7 -174.61% | -52,3 | -66,7 -57,3 -16.56% | -68,1 -67,6 -0.78% | -82,2 -73,4 -12.02% | -101 -78,7 -28.55% | -76,2 2,10 -3726.81% | -85,4 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 11,1 -39,8 127.95% | 467 -23,0 2131.96% | 174 | -156 -40,2 -287.17% | -94,9 -67,8 -40.02% | 36,0 -74,0 148.63% | -56,0 -71,7 21.93% | -13,7 24,6 -155.87% | -73,4 | |
|
Net income Million USD | Released Forecast Spread | 28,3 -28,0 201.22% | 393 -10,4 3876.94% | 124 | -118 -39,3 -200.44% | -75,4 -67,8 -11.2% | 14,8 -74,0 120.06% | -28,3 -72,0 60.61% | -22,0 9,70 -326.91% | -25,0 7,30 -442.52% | -91,4 |
|
EPS USD | Released Forecast Spread | 0,10 -0,10 200% | 0,42 | -0,40 -1,03 60.98% | -0,10 -0,20 50% | -0,09 0,10 -190% | -0,30 | ||||
| Announcement Date | 08/27/19 | 04/09/20 | 08/27/20 | 04/15/21 | 08/24/21 | 04/26/22 | 08/25/22 | 04/28/23 | 08/29/23 | - |
| 2024-01-22 | Q3 2024 Earnings Release (Projected) |
| 2024-01-23 | Q4 2023 Earnings Release (Projected) |
| 2024-01-31 | Q3 2023 Earnings Release (Projected) |
| 2024-02-02 12:45 am | Q4 2023 Earnings Release |
| 2024-02-05 | Q1 2024 Earnings Release (Projected) |
| 2024-02-05 | Q2 2024 Earnings Release (Projected) |
| 2024-02-05 | Q4 2023 Earnings Release (Projected) |
| 2024-02-06 | Q1 2024 Earnings Release (Projected) |
| 2024-02-07 | Q4 2023 Earnings Release (Projected) |
| 2024-02-07 | Q4 2023 Earnings Release (Projected) |
Past sector events for PureTech Health plc
| 2023-11-27 | Q3 2023 Earnings Release |
| 2023-11-15 | Q3 2023 Earnings Release (Projected) |
| 2023-11-15 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-14 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-11-14 06:30 am | Q3 2023 Earnings Release |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-11-13 08:15 pm | Q3 2023 Earnings Release |
| 2023-11-13 04:07 pm | Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock PureTech Health plc - London Stock Exchange
- Calendar PureTech Health plc